173 related articles for article (PubMed ID: 37767401)
1. Comparison of the efficacy and safety of different doses of atropine for myopic control in children: a meta-analysis.
Hou P; Wu D; Nie Y; Wei H; Liu L; Yang G
Front Pharmacol; 2023; 14():1227787. PubMed ID: 37767401
[No Abstract] [Full Text] [Related]
2. Efficacy and safety of atropine in myopic children: A meta-analysis of randomized controlled trials.
Long H; Shi MH; Li X
J Fr Ophtalmol; 2023 Oct; 46(8):929-940. PubMed ID: 37147148
[TBL] [Abstract][Full Text] [Related]
3. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and Adverse Effects of Atropine in Childhood Myopia: A Meta-analysis.
Gong Q; Janowski M; Luo M; Wei H; Chen B; Yang G; Liu L
JAMA Ophthalmol; 2017 Jun; 135(6):624-630. PubMed ID: 28494063
[TBL] [Abstract][Full Text] [Related]
5. Varying Dose of Atropine in Slowing Myopia Progression in Children Over Different Follow-Up Periods by Meta-Analysis.
Gan J; Li SM; Wu S; Cao K; Ma D; He X; Hua Z; Kang MT; Wei S; Bai W; Wang N
Front Med (Lausanne); 2021; 8():756398. PubMed ID: 35096861
[No Abstract] [Full Text] [Related]
6. Efficacy and Safety of 8 Atropine Concentrations for Myopia Control in Children: A Network Meta-Analysis.
Ha A; Kim SJ; Shim SR; Kim YK; Jung JH
Ophthalmology; 2022 Mar; 129(3):322-333. PubMed ID: 34688698
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of atropine at different concentrations in prevention of myopia progression in Asian children: a systematic review and Meta-analysis of randomized clinical trials.
Wei XL; Wu T; Dang KR; Hu KK; Lu XT; Gong M; Du YR; Hui YN; Tian XM; Du HJ
Int J Ophthalmol; 2023; 16(8):1326-1336. PubMed ID: 37602338
[TBL] [Abstract][Full Text] [Related]
8. Interventions to slow progression of myopia in children.
Walline JJ; Lindsley KB; Vedula SS; Cotter SA; Mutti DO; Ng SM; Twelker JD
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004916. PubMed ID: 31930781
[TBL] [Abstract][Full Text] [Related]
9. The efficacy and safety of 0.01% atropine alone or combined with orthokeratology for children with myopia: A meta-analysis.
Wang Z; Wang P; Jiang B; Meng Y; Qie S; Yan Z
PLoS One; 2023; 18(7):e0282286. PubMed ID: 37494360
[TBL] [Abstract][Full Text] [Related]
10. The synergistic efficacy and safety of combined low-concentration atropine and orthokeratology for slowing the progression of myopia: A meta-analysis.
Zheng NN; Tan KW
Ophthalmic Physiol Opt; 2022 Nov; 42(6):1214-1226. PubMed ID: 35919929
[TBL] [Abstract][Full Text] [Related]
11. Efficacy Comparison of 16 Interventions for Myopia Control in Children: A Network Meta-analysis.
Huang J; Wen D; Wang Q; McAlinden C; Flitcroft I; Chen H; Saw SM; Chen H; Bao F; Zhao Y; Hu L; Li X; Gao R; Lu W; Du Y; Jinag Z; Yu A; Lian H; Jiang Q; Yu Y; Qu J
Ophthalmology; 2016 Apr; 123(4):697-708. PubMed ID: 26826749
[TBL] [Abstract][Full Text] [Related]
12. Is 0.01% Atropine an Effective and Safe Treatment for Myopic Children? A Systemic Review and Meta-Analysis.
Tsai HR; Chen TL; Wang JH; Huang HK; Chiu CJ
J Clin Med; 2021 Aug; 10(17):. PubMed ID: 34501214
[TBL] [Abstract][Full Text] [Related]
13. Myopia progression after cessation of atropine in children: a systematic review and meta-analysis.
Lee SH; Tsai PC; Chiu YC; Wang JH; Chiu CJ
Front Pharmacol; 2024; 15():1343698. PubMed ID: 38318144
[No Abstract] [Full Text] [Related]
14. Safety and Efficacy of Low-Dose Atropine Eyedrops for the Treatment of Myopia Progression in Chinese Children: A Randomized Clinical Trial.
Wei S; Li SM; An W; Du J; Liang X; Sun Y; Zhang D; Tian J; Wang N
JAMA Ophthalmol; 2020 Nov; 138(11):1178-1184. PubMed ID: 33001210
[TBL] [Abstract][Full Text] [Related]
15. Atropine for the treatment of childhood myopia: safety and efficacy of 0.5%, 0.1%, and 0.01% doses (Atropine for the Treatment of Myopia 2).
Chia A; Chua WH; Cheung YB; Wong WL; Lingham A; Fong A; Tan D
Ophthalmology; 2012 Feb; 119(2):347-54. PubMed ID: 21963266
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Adverse Effects of Atropine for Myopia Control in Children: A Meta-Analysis of Randomised Controlled Trials.
Chen C; Yao J
J Ophthalmol; 2021; 2021():4274572. PubMed ID: 34925913
[TBL] [Abstract][Full Text] [Related]
17. The optimal atropine concentration for myopia control in Chinese children: a systematic review and network Meta-analysis.
Wang XY; Deng HW; Yang J; Zhu XM; Xiang FL; Tu J; Huang MX; Wang Y; Gan JH; Yang WH
Int J Ophthalmol; 2024; 17(6):1128-1137. PubMed ID: 38895669
[TBL] [Abstract][Full Text] [Related]
18. Low-Concentration Atropine for Myopia Progression (LAMP) Study: A Randomized, Double-Blinded, Placebo-Controlled Trial of 0.05%, 0.025%, and 0.01% Atropine Eye Drops in Myopia Control.
Yam JC; Jiang Y; Tang SM; Law AKP; Chan JJ; Wong E; Ko ST; Young AL; Tham CC; Chen LJ; Pang CP
Ophthalmology; 2019 Jan; 126(1):113-124. PubMed ID: 30514630
[TBL] [Abstract][Full Text] [Related]
19. The effect of 0.01% atropine on ocular axial elongation for myopia children: A protocol for systematic review and meta-analysis.
Gao Y; Yu Y
Medicine (Baltimore); 2022 Jun; 101(22):e29409. PubMed ID: 35665735
[TBL] [Abstract][Full Text] [Related]
20. Atropine slows myopia progression more in Asian than white children by meta-analysis.
Li SM; Wu SS; Kang MT; Liu Y; Jia SM; Li SY; Zhan SY; Liu LR; Li H; Chen W; Yang Z; Sun YY; Wang N; Millodot M
Optom Vis Sci; 2014 Mar; 91(3):342-50. PubMed ID: 24445721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
